SG10201503504VA - Novel Antimicrobial Compounds And Uses Thereof - Google Patents
Novel Antimicrobial Compounds And Uses ThereofInfo
- Publication number
- SG10201503504VA SG10201503504VA SG10201503504VA SG10201503504VA SG10201503504VA SG 10201503504V A SG10201503504V A SG 10201503504VA SG 10201503504V A SG10201503504V A SG 10201503504VA SG 10201503504V A SG10201503504V A SG 10201503504VA SG 10201503504V A SG10201503504V A SG 10201503504VA
- Authority
- SG
- Singapore
- Prior art keywords
- antimicrobial compounds
- novel antimicrobial
- novel
- compounds
- antimicrobial
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/03—Monocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/377—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33472710P | 2010-05-14 | 2010-05-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201503504VA true SG10201503504VA (en) | 2015-06-29 |
Family
ID=44914590
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201503504VA SG10201503504VA (en) | 2010-05-14 | 2011-05-12 | Novel Antimicrobial Compounds And Uses Thereof |
SG2012083242A SG185528A1 (en) | 2010-05-14 | 2011-05-12 | Novel antimicrobial compounds and uses thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2012083242A SG185528A1 (en) | 2010-05-14 | 2011-05-12 | Novel antimicrobial compounds and uses thereof |
Country Status (4)
Country | Link |
---|---|
US (2) | US8785680B2 (en) |
EP (2) | EP3354635A1 (en) |
SG (2) | SG10201503504VA (en) |
WO (1) | WO2011142724A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE112008001301T5 (en) | 2007-05-14 | 2010-04-29 | Reserach Foundation Of State University Of New York | Induction of a physiological dispersion response in bacterial cells in a biofilm |
KR101749687B1 (en) | 2016-04-25 | 2017-06-21 | 경북대학교 산학협력단 | Antibacterial agent comprising 7,10-epoxy-octadeca-7,9-dienoic acid |
KR101792239B1 (en) | 2016-11-01 | 2017-10-31 | 경북대학교 산학협력단 | Antibacterial agent comprising 7,10-epoxy-octadeca-7,9-dienoic acid and antibiotics |
US10695314B2 (en) | 2016-04-25 | 2020-06-30 | Kyungpook National University Industry-Academic Cooperation Foundation | Antimicrobial composition containing 7,10-epoxyoctadeca-7,9-dienoic acid as active ingredient |
CN107417520A (en) * | 2017-05-12 | 2017-12-01 | 华南农业大学 | A kind of Burkholderia cepacia antimicrobial compound and preparation method and application |
CN108911969B (en) * | 2018-08-02 | 2021-06-22 | 重庆市中药研究院 | Compound for preventing and treating citrus canker and application thereof |
US11197824B2 (en) * | 2020-01-16 | 2021-12-14 | David Changaris | Solution and method for reducing the virulence of viruses, bacteria,yeasts, or fungus |
US20230142090A1 (en) * | 2020-04-01 | 2023-05-11 | Cornell University | Compositions and methods for inhibiting vibrio infection |
CN113402385B (en) * | 2021-07-20 | 2022-08-26 | 湖北大学 | Antibacterial compound derived from fungal metabolite, preparation method and application |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3146256A (en) | 1957-10-10 | 1964-08-25 | Montedison Spa | Preparation of alpha-beta, delta-epsilon unsaturated carboxylic derivatives |
US3236879A (en) | 1957-10-10 | 1966-02-22 | Montedison Spa | Preparation of alpha-beta, deltaepsilon unsaturated carboxylic acids and esters |
DE1109671B (en) | 1958-10-17 | 1961-06-29 | Basf Ag | Process for the production of ª ‡, ª ‰ -unsaturated carboxylic acid esters or the free acids |
NL129288C (en) | 1965-02-04 | |||
US4021461A (en) | 1971-11-22 | 1977-05-03 | Zoecon Corporation | Aliphatic hydrocarbon 2,4-dienoic acids, esters and derivatives thereof |
DE3347128A1 (en) * | 1983-12-22 | 1985-07-11 | Schering AG, 1000 Berlin und 4709 Bergkamen | 9-HALOGEN- (DELTA) (ARROW HIGH) 2 (ARROW HIGH) -PROSTAGLAND IN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS |
US4575512A (en) * | 1984-11-01 | 1986-03-11 | E. R. Squibb & Sons, Inc. | 7-Oxabicycloheptane substituted oxa prostaglandin analogs and their anti-thrombotic compositions and methods |
WO2003039529A1 (en) | 2001-11-07 | 2003-05-15 | 4Sc A.G. | Selective antibacterial agents |
US7135575B2 (en) * | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
EP1763528B1 (en) * | 2004-07-05 | 2008-11-26 | Astellas Pharma Inc. | Pyrazolopyridine derivatives |
-
2011
- 2011-05-12 US US13/697,993 patent/US8785680B2/en not_active Expired - Fee Related
- 2011-05-12 WO PCT/SG2011/000183 patent/WO2011142724A1/en active Application Filing
- 2011-05-12 SG SG10201503504VA patent/SG10201503504VA/en unknown
- 2011-05-12 SG SG2012083242A patent/SG185528A1/en unknown
- 2011-05-12 EP EP18159491.2A patent/EP3354635A1/en not_active Withdrawn
- 2011-05-12 EP EP11780893.1A patent/EP2569273B1/en not_active Not-in-force
-
2014
- 2014-02-12 US US14/179,286 patent/US9012505B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20140256812A1 (en) | 2014-09-11 |
EP2569273B1 (en) | 2018-04-04 |
EP2569273A4 (en) | 2014-03-26 |
SG185528A1 (en) | 2012-12-28 |
US20130131172A1 (en) | 2013-05-23 |
EP3354635A1 (en) | 2018-08-01 |
US9012505B2 (en) | 2015-04-21 |
US8785680B2 (en) | 2014-07-22 |
WO2011142724A1 (en) | 2011-11-17 |
EP2569273A1 (en) | 2013-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201301301B (en) | Antimicrobial formulation | |
EP2549993A4 (en) | Antimicrobial compositions | |
EP2635285A4 (en) | Heteroaryl compounds and uses thereof | |
EP2563956A4 (en) | Antimicrobial substrate | |
HRP20160922T1 (en) | Oligopeptidic compounds and uses thereof | |
ZA201205516B (en) | Antimicrobial compounds and fibers thereof | |
SG10201503504VA (en) | Novel Antimicrobial Compounds And Uses Thereof | |
EP2582246A4 (en) | Biocidal composition | |
ZA201303773B (en) | Compounds and their use | |
EP2575453A4 (en) | Oligo-benzamide compounds and their use | |
SI2654440T1 (en) | Microbicidal composition | |
EP2627172A4 (en) | An antimicrobial composition | |
EP2753341A4 (en) | Antimicrobial compositions and uses thereof | |
EP2615094A4 (en) | Sesterterpene compounds and use thereof | |
GB201002673D0 (en) | Antimicrobial agent | |
GB201022132D0 (en) | Anti-microbial composition | |
GB201001632D0 (en) | Antimicrobial compounds | |
GB201015592D0 (en) | Antimicrobial materials | |
GB201014319D0 (en) | Compounds and uses thereof | |
GB201021626D0 (en) | Novel antimicrobial compounds | |
GB201005921D0 (en) | Antimicrobial compositions and uses | |
EP2567956A4 (en) | Novel prenylarene compound and use thereof | |
AU2011904886A0 (en) | Antimicrobial compounds and uses thereof | |
GB201111128D0 (en) | Antimicrobial compositions | |
GB201013150D0 (en) | Antimicrobial compositions |